BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 30390688)

  • 1. Diagnostic value of the gynecology imaging reporting and data system (GI-RADS) with the ovarian malignancy marker CA-125 in preoperative adnexal tumor assessment.
    Migda M; Bartosz M; Migda MS; Kierszk M; Katarzyna G; Maleńczyk M
    J Ovarian Res; 2018 Nov; 11(1):92. PubMed ID: 30390688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of the diagnostic value of using serum CA125 and GI-RADS system in the evaluation of adnexal masses.
    Zheng H; Tie Y; Wang X; Yang Y; Wei X; Zhao X
    Medicine (Baltimore); 2019 Feb; 98(7):e14577. PubMed ID: 30762809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic performance of the Gynecology Imaging Reporting and Data System for malignant adnexal masses.
    Zhang T; Li F; Liu J; Zhang S
    Int J Gynaecol Obstet; 2017 Jun; 137(3):325-331. PubMed ID: 28295272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GI-RADS reporting system for ultrasound evaluation of adnexal masses in clinical practice: a prospective multicenter study.
    Amor F; Alcázar JL; Vaccaro H; León M; Iturra A
    Ultrasound Obstet Gynecol; 2011 Oct; 38(4):450-5. PubMed ID: 21465605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of adnexal lesions using photoacoustic imaging to improve sonographic O-RADS risk assessment.
    Zhu Q; Luo H; Middleton WD; Itani M; Hagemann IS; Hagemann AR; Hoegger MJ; Thaker PH; Kuroki LM; MCourt CK; Mutch DG; Powell MA; Siegel CL
    Ultrasound Obstet Gynecol; 2023 Dec; 62(6):891-903. PubMed ID: 37606287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gynecologic imaging reporting and data system: a new proposal for classifying adnexal masses on the basis of sonographic findings.
    Amor F; Vaccaro H; Alcázar JL; León M; Craig JM; Martinez J
    J Ultrasound Med; 2009 Mar; 28(3):285-91. PubMed ID: 19244063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the importance of the serum levels of CA-125, CA15-3, CA-19-9, carcinoembryonic antigen and alpha fetoprotein for distinguishing benign and malignant adnexal masses and contribution of different test combinations to diagnostic accuracy.
    Bozkurt M; Yumru AE; Aral I
    Eur J Gynaecol Oncol; 2013; 34(6):540-4. PubMed ID: 24601047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of IOTA Simple Rules, Simple Rules risk assessment, ADNEX model and O-RADS in differentiating between benign and malignant adnexal lesions in North American women.
    Hiett AK; Sonek JD; Guy M; Reid TJ
    Ultrasound Obstet Gynecol; 2022 May; 59(5):668-676. PubMed ID: 34533862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of IOTA ADNEX model in evaluating adnexal masses in a gynecological oncology center in China.
    Chen H; Qian L; Jiang M; Du Q; Yuan F; Feng W
    Ultrasound Obstet Gynecol; 2019 Dec; 54(6):815-822. PubMed ID: 31152572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of IOTA simple rules, O-RADS, and CA125 to distinguish benign and malignant adnexal masses.
    Xie WT; Wang YQ; Xiang ZS; Du ZS; Huang SX; Chen YJ; Tang LN
    J Ovarian Res; 2022 Jan; 15(1):15. PubMed ID: 35067220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gynecology Imaging Reporting and Data System (GI-RADS): diagnostic performance and inter-reviewer agreement.
    Basha MAA; Refaat R; Ibrahim SA; Madkour NM; Awad AM; Mohamed EM; El Sammak AA; Zaitoun MMA; Dawoud HA; Khamis MEM; Mohamed HAE; El-Maghraby AM; Abdalla AAEM; Assy MM; Nada MG; Obaya AA; Abdelbary EH
    Eur Radiol; 2019 Nov; 29(11):5981-5990. PubMed ID: 30993433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adding a single CA 125 measurement to ultrasound imaging performed by an experienced examiner does not improve preoperative discrimination between benign and malignant adnexal masses.
    Valentin L; Jurkovic D; Van Calster B; Testa A; Van Holsbeke C; Bourne T; Vergote I; Van Huffel S; Timmerman D
    Ultrasound Obstet Gynecol; 2009 Sep; 34(3):345-54. PubMed ID: 19585547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discrimination between benign and malignant adnexal masses by specialist ultrasound examination versus serum CA-125.
    Van Calster B; Timmerman D; Bourne T; Testa AC; Van Holsbeke C; Domali E; Jurkovic D; Neven P; Van Huffel S; Valentin L
    J Natl Cancer Inst; 2007 Nov; 99(22):1706-14. PubMed ID: 18000221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic accuracy of gynecology imaging reporting and data system in evaluation of adnexal lesions.
    Behnamfar F; Adibi A; Khadra H; Moradi M
    J Res Med Sci; 2019; 24():57. PubMed ID: 31523243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IETA Ultrasonic Features Combined with GI-RADS Classification System and Tumor Biomarkers for Surveillance of Endometrial Carcinoma: An Innovative Study.
    Lin D; Wang H; Liu L; Zhao L; Chen J; Tian H; Gao L; Wu B; Zhang J; Guo X; Hao Y
    Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428723
    [No Abstract]   [Full Text] [Related]  

  • 16. The use of sonographic subjective tumor assessment, IOTA logistic regression model 1, IOTA Simple Rules and GI-RADS system in the preoperative prediction of malignancy in women with adnexal masses.
    Koneczny J; Czekierdowski A; Florczak M; Poziemski P; Stachowicz N; Borowski D
    Ginekol Pol; 2017; 88(12):647-653. PubMed ID: 29303221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sonographic discrimination between benign and malignant adnexal masses in premenopause.
    Radosa MP; Vorwergk J; Fitzgerald J; Kaehler C; Schneider U; Camara O; Runnebaum IB; Schleußner E
    Ultraschall Med; 2014 Aug; 35(4):339-44. PubMed ID: 23775448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective study to evaluate the risk malignancy index and its diagnostic implication in patients with suspected ovarian mass.
    Dora SK; Dandapat AB; Pande B; Hota JP
    J Ovarian Res; 2017 Aug; 10(1):55. PubMed ID: 28806987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CA 19-9 in evaluation of adnexal mass: retrospective cohort analysis and review of the literature.
    Sagi-Dain L; Lavie O; Auslander R; Sagi S
    Int J Biol Markers; 2015 Jul; 30(3):e333-40. PubMed ID: 25704505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving risk stratification of indeterminate adnexal masses on MRI: What imaging features help predict malignancy in O-RADS MRI 4 lesions?
    Wong BZY; Causa Andrieu PI; Sonoda Y; Chi DS; Aviki EM; Vargas HA; Woo S
    Eur J Radiol; 2023 Nov; 168():111122. PubMed ID: 37806193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.